No definition available.
Iridocyclitis in diseases classified elsewhere
DOID EFO Endpoint Browser PheWeb
H7_IRIDOCYCLITISINOTH
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
659 |
4. Check minimum number of eventsNone |
659 |
5. Include endpointsNone |
659 |
6. Filter based on genotype QC (FinnGen only) |
659 |
Control definitions (FinnGen only)
- Control exclude
- H7_SCLERACORNEA
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Iridocyclitis in diseases classified elsewhere
based on the number of shared cases.
Similar with more cases:
- Iridocyclitis
- Disorders of sclera, cornea, iris and ciliary body
- Diseases of the eye and adnexa
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 3920 | 2066 | 1843 |
| Only index persons | 3697 | 1955 | 1742 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.06 | 0.06 | 0.05 |
| Only index persons | 0.07 | 0.07 | 0.07 |
| Median age at first event (years) | |||
| Whole population | 53.62 | 55.44 | 51.59 |
| Only index persons | 53.59 | 55.89 | 51.00 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 659 | 367 | 292 |
| Unadjusted period prevalence (%) | 0.13 | 0.13 | 0.13 |
| Median age at first event (years) | 54.69 | 52.90 | 56.95 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 585
- Matched controls
- 5851
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
+∞
322.8
279
*
H22.1*M45
ICD-10 Finland
Iridocyclitis in ankylosing spondylitis
+∞
215.3
193
*
M45
ICD-10 Finland
Ankylosing spondylitis
90.8
175.9
191
31
H20.1
ICD-10 Finland
Chronic iridocyclitis
+∞
175.0
159
*
H22.0*B02.3
ICD-10 Finland
Zoster iridocyclitis
+∞
153.0
140
*
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
15.5
149.7
277
321
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
13.8
116.8
221
247
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
48.5
116.3
141
38
A07EC01
ATC
sulfasalazine; oral, rectal
14.9
111.1
200
197
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
44.7
103.0
127
36
S01BA04
ATC
prednisolone; ophthalmic (corticosteroids, plain)
37.0
92.6
119
40
S01AD03
ATC
aciclovir; ophthalmic
25.2
91.5
131
66
H22.0*B00.5
ICD-10 Finland
Herpesviral iridocyclitis
+∞
89.9
84
*
S01BA01
ATC
dexamethasone; ophthalmic (corticosteroids, plain)
23.0
89.4
132
73
H22.1*D86.8
ICD-10 Finland
Iridocyclitis in sarcoidosis
+∞
83.3
78
*
L04AB04
ATC
adalimumab; parenteral
40.5
82.7
104
31
H22.1
ICD-10 Finland
Iridocyclitis in other diseases classified elsewhere
+∞
77.9
73
*
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
16.1
73.1
123
95
S01ED51
ATC
timolol, combinations; ophthalmic
10.8
70.4
145
173
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
10.5
67.4
141
172
H19.1*B00.5
ICD-10 Finland
Herpesviral keratoconjunctivitis
+∞
63.7
60
*
H19.2*B02.3
ICD-10 Finland
Keratitis and keratoconjunctivitis (interstitial) in zoster
+∞
63.7
60
*
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
9.8
62.8
136
175
S01CA02
ATC
prednisolone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
52.0
57.9
69
15
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
4.2
57.1
334
1416
H02AB06
ATC
prednisolone; systemic
3.9
52.5
381
1896
D86.8
ICD-10 Finland
Sarcoidosis of other and combined sites
101.0
50.8
55
6
S01FA04
ATC
cyclopentolate; ophthalmic
48.5
50.6
61
14
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
65.9
47.2
54
9
L04AB01
ATC
etanercept; parenteral
33.9
46.9
61
20
J05AB11
ATC
valaciclovir; oral
5.3
46.4
161
390
Z01.0
ICD-10 Finland
Examination of eyes and vision
4.7
46.0
185
525
J05AB01
ATC
aciclovir; systemic
4.2
45.2
211
690
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
3.7
45.1
283
1193
H22.0
ICD-10 Finland
Iridocyclitis in infectious and parasitic diseases classified elsewhere
+∞
44.3
42
*
M08.4
ICD-10 Finland
Pauciarticular juvenile arthritis
118.7
41.3
44
*
S01ED01
ATC
timolol; ophthalmic
12.0
40.9
77
73
B02.3
ICD-10 Finland
Zoster ocular disease
90.4
38.3
42
5
L04AA13
ATC
leflunomide; oral
16.1
37.2
61
42
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.3
36.6
256
1123
L04AB06
ATC
golimumab; parenteral
73.2
36.5
41
6
H26.2
ICD-10 Finland
Complicated cataract
29.9
35.2
47
17
D86.0
ICD-10 Finland
Sarcoidosis of lung
27.6
33.7
46
18
H221, M084
ICD-10 Finland
NA
+∞
33.7
32
*
H30.2
ICD-10 Finland
Posterior cyclitis
345.5
33.2
33
*
Z96.1
ICD-10 Finland
Presence of intraocular lens
4.8
33.1
123
310
H20.9
ICD-10 Finland
Iridocyclitis, unspecified
123.8
33.0
35
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.9
32.1
313
1671
7200A
ICD-9 Finland
Ankylosing spondylitis and other inflammatory spondylopathies, Ankylosing spondylitis
120.1
32.0
34
*
XCW99
NOMESCO Finland
Other investigative procedure of eye
4.5
30.0
117
308
114
Kela drug reimbursment
Glaucoma
5.4
29.8
95
201
M08.3
ICD-10 Finland
Juvenile polyarthritis (seronegative)
60.0
29.4
34
6
H02AB07
ATC
prednisone; oral
3.8
29.0
138
435
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
4.8
28.8
104
252
P01BA02
ATC
hydroxychloroquine; oral
5.2
28.4
95
212
H40.4
ICD-10 Finland
Glaucoma secondary to eye inflammation
+∞
28.4
27
*
B02.9
ICD-10 Finland
Zoster without complication
6.6
27.9
75
128
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
13.7
27.6
48
38
H16.0
ICD-10 Finland
Corneal ulcer
15.6
27.4
45
31
H16.9
ICD-10 Finland
Keratitis, unspecified
101.5
26.9
29
*
H221, M083
ICD-10 Finland
NA
+∞
26.2
25
*
H19.1
ICD-10 Finland
Herpesviral keratitis and keratoconjunctivitis
+∞
26.2
25
*
M46.1
ICD-10 Finland
Sacroiliitis, not elsewhere classified
23.1
26.0
37
17
B00.5
ICD-10 Finland
Herpesviral ocular disease
141.2
25.8
27
*
S01EA03
ATC
apraclonidine; ophthalmic
34.9
25.8
33
10
S01BA07
ATC
fluorometholone; ophthalmic (corticosteroids, plain)
16.4
25.0
40
26
S01EC01
ATC
acetazolamide; systemic
11.8
24.8
46
42
D86.9
ICD-10 Finland
Sarcoidosis, unspecified
29.0
24.7
33
12
L88
ICPC
Rheumatoid/seropositive arthritis
7.4
24.6
60
89
NA6BG
NOMESCO Finland
Sacro-iliac joint MRI examination with high intensity magnet
16.6
24.5
39
25
S01EA05
ATC
brimonidine; ophthalmic (sympathomimetics in glaucoma therapy)
11.2
24.3
46
44
L04AX01
ATC
azathioprine; systemic
6.3
23.4
64
111
S01FA02
ATC
scopolamine; ophthalmic
21.1
23.3
34
17
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
2.7
23.2
202
958
L04AA11
ATC
[U] etanercept; parenteral
47.0
22.5
27
6
M46.9
ICD-10 Finland
Inflammatory spondylopathy, unspecified
19.4
22.0
33
18
H04.10
ICD-10 Finland
Dry eye syndrome
3.8
20.3
92
273
M08.0
ICD-10 Finland
Juvenile rheumatoid arthritis
37.2
20.0
25
7
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
4.8
19.7
69
160
TCA20
NOMESCO Finland
Peribulbar therapeutic injection into orbit
206.6
19.7
20
*
S01BC03
ATC
diclofenac; ophthalmic
9.1
19.5
41
48
S01EE01
ATC
latanoprost; ophthalmic
5.4
19.3
60
122
M13.9
ICD-10 Finland
Arthritis, unspecified
4.2
18.7
74
194
S01EC04
ATC
brinzolamide; ophthalmic
7.0
18.5
46
70
ZXA10
NOMESCO Finland
Bilateral
2.7
18.3
142
615
H57.1
ICD-10 Finland
Ocular pain
7.7
17.6
41
57
D86.2
ICD-10 Finland
Sarcoidosis of lung with sarcoidosis of lymph nodes
21.7
17.4
25
12
L04AA01
ATC
[U] ciclosporin; systemic
12.1
17.2
31
27
L04AB05
ATC
certolizumab pegol; parenteral
32.6
17.1
22
7
H20
ICD-10 Finland
Iridocyclitis
65.3
16.8
19
*
36400
ICD-8 Finland
Iritis, Iridocyclitis acuta
+∞
16.7
16
*
CG2S4
NOMESCO Finland
Photography of cornea
174.7
16.6
17
*
XCK10
NOMESCO Finland
Photography of fundus of eye
3.3
16.1
88
299
H40.0
ICD-10 Finland
Glaucoma suspect
4.0
15.9
65
176
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
4.5
15.7
56
133
L04AA17
ATC
[U] adalimumab; parenteral
39.2
15.5
19
5
4AA12
NOMESCO Finland
NA
29.5
15.3
20
7
CJB10
NOMESCO Finland
Laser discission of secondary cataract
3.7
15.2
69
204
A02BC02
ATC
pantoprazole; systemic
2.1
15.2
385
2829
TCF00
NOMESCO Finland
Subconjunctival therapeutic injection
58.2
14.9
17
*
N03AX16
ATC
pregabalin; oral
2.3
14.8
160
819
H03.1*B02.3
ICD-10 Finland
Zoster blepharitis
25.8
14.8
20
8
WZA10
NOMESCO Finland
Long statement of health and health related matters
12.3
14.7
26
22
3640A
ICD-9 Finland
Disorders of iris and ciliary body, Acute and subacute iridocyclitis
+∞
14.6
14
*
H20.8
ICD-10 Finland
Other iridocyclitis
+∞
14.6
14
*
71240
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Spondylitis ankylopoietica
37.0
14.5
18
5
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.2
13.9
183
1018
D86
ICD-10 Finland
Sarcoidosis
+∞
13.6
13
*
132
Kela drug reimbursment
Sarcoidosis
16.7
13.5
21
13
H19.2
ICD-10 Finland
Keratitis and keratoconjunctivitis in other infectious and parasitic diseases classified elsewhere
143.1
13.5
14
*
N02AX02
ATC
tramadol; systemic, rectal
2.0
13.4
251
1606
H26.4
ICD-10 Finland
After-cataract
3.3
13.4
70
231
H25.1
ICD-10 Finland
Senile nuclear cataract
2.3
13.2
146
748
UJF32
NOMESCO Finland
Coloscopy
2.2
13.1
162
874
S01EE04
ATC
travoprost; ophthalmic
8.3
12.9
28
35
TNH11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in ankle joint or foot joint
17.8
12.6
19
11
ZX120
NOMESCO Finland
Intravenous
2.9
12.3
79
300
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
8.7
11.9
25
30
B02
ICD-10 Finland
Zoster [herpes zoster]
5.3
11.9
36
72
XCK00
NOMESCO Finland
Perimetry
3.6
11.8
54
161
4AB02
NOMESCO Finland
NA
30.7
11.7
15
5
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.0
11.7
68
243
S01EE05
ATC
tafluprost; ophthalmic
5.7
11.7
33
61
M01AH01
ATC
celecoxib; oral (coxibs)
2.3
11.6
117
570
S01BC05
ATC
ketorolac; ophthalmic
4.5
11.4
40
94
M01CB01
ATC
sodium aurothiomalate; parenteral
10.8
11.3
21
20
H26.3
ICD-10 Finland
Drug-induced cataract
13.0
11.2
19
15
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
3.5
11.2
53
163
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.9
11.1
71
268
CHD50
NOMESCO Finland
Shunt operation on anterior chamber
44.2
11.0
13
*
TCG10
NOMESCO Finland
Removal of sutures from cornea
44.2
11.0
13
*
S01FA06
ATC
tropicamide; ophthalmic
44.2
11.0
13
*
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
3.3
10.5
53
171
M05BA04
ATC
alendronic acid; oral
3.0
10.5
61
218
WX100
NOMESCO Finland
Conjunctival surface anesthesia
2.7
10.4
75
306
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
3.5
10.4
48
145
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
4.9
10.1
32
68
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.8
10.1
244
1664
H35.39
ICD-10 Finland
Degeneration of macula and posterior pole
5.2
10.0
30
60
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
5.8
9.9
27
48
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
7.2
9.9
23
33
NK5AT
NOMESCO Finland
Joint injection with ultrasound guidance not elsewhere classified
13.7
9.7
16
12
M01AX01
ATC
nabumetone; oral
4.2
9.7
36
90
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.7
9.4
63
246
G53.0*B02.20
ICD-10 Finland
Trigeminal neuralgia after shingles
30.6
9.4
12
*
TNG11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in knee
12.6
9.4
16
13
H21.1
ICD-10 Finland
Other vascular disorders of iris and ciliary body
+∞
9.4
9
*
K50.8
ICD-10 Finland
Other Crohn disease
7.1
9.4
22
32
L04AC10
ATC
secukinumab; parenteral
22.1
9.4
13
6
B02.8
ICD-10 Finland
Zoster with other complications
22.1
9.4
13
6
N02BE01
ATC
paracetamol; systemic, rectal
2.0
9.3
487
4191
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
7.5
9.3
21
29
G53.0
ICD-10 Finland
Postzoster neuralgia
15.9
9.1
14
9
D86.3
ICD-10 Finland
Sarcoidosis of skin
37.3
9.0
11
*
R4110
NOMESCO Finland
Physiotherapy
1.9
9.0
165
1017
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.0
8.9
133
759
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
3.5
8.9
41
124
M01AC06
ATC
meloxicam; systemic, rectal
1.8
8.9
208
1391
N03AX12
ATC
gabapentin; oral
2.2
8.8
91
448
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
4.6
8.8
29
65
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
3.5
8.7
40
121
CFW99
NOMESCO Finland
Other operation on conjunctiva
50.7
8.7
10
*
S01EC03
ATC
dorzolamide; ophthalmic
7.1
8.6
20
29
J01FA06
ATC
roxithromycin; oral
1.7
8.6
229
1588
H10.8
ICD-10 Finland
Other conjunctivitis
20.4
8.5
12
6
NAJ12
NOMESCO Finland
Posterior reduction of fracture of cervical spine
91.3
8.4
9
*
3641A
ICD-9 Finland
Disorders of iris and ciliary body, Chronic iridocyclitis
+∞
8.3
8
*
H22.0*A69.2
ICD-10 Finland
Iridocyclitis in Lyme disease
+∞
8.3
8
*
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
9.6
8.3
16
17
L04AD01
ATC
ciclosporin; systemic
5.5
8.2
23
43
M02.9
ICD-10 Finland
Reactive arthropathy, unspecified
6.2
8.2
21
35
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.8
8.2
162
1022
TNG10
NOMESCO Finland
Puncture of knee
8.3
8.1
17
21
K50.0
ICD-10 Finland
Crohn disease of small intestine
8.3
8.1
17
21
CHC05
NOMESCO Finland
Iridotomy
8.3
8.1
17
21
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
2.3
8.1
73
336
H15.1
ICD-10 Finland
Episcleritis
17.5
8.1
12
7
WX140
NOMESCO Finland
Parabulbar anesthesy
3.9
8.1
32
86
NF1AA
NOMESCO Finland
Hip X-ray examination
2.7
8.0
54
211
H40.13
ICD-10 Finland
Chronic glaucoma with open ventricular angle
3.8
8.0
32
87
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.6
8.0
58
239
M01AE02
ATC
naproxen; oral, rectal
1.6
7.9
329
2565
D86.1
ICD-10 Finland
Sarcoidosis of lymph nodes
11.0
7.8
14
13
M01AH02
ATC
rofecoxib; oral
2.2
7.8
80
391
J01DB01
ATC
cefalexin; oral
1.8
7.8
468
4041
S01EE03
ATC
bimatoprost; ophthalmic
5.2
7.8
23
46
R05
ICD-10 Finland
Cough
2.0
7.8
114
644
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
7.7
159
1014
WX002
NOMESCO Finland
Sedation and analgesia
1.9
7.6
115
657
ZXA05
NOMESCO Finland
Left side
1.8
7.6
147
914
NG1AE
NOMESCO Finland
Knee joint ultrasound exmination
8.2
7.6
16
20
ZXA00
NOMESCO Finland
Right side
1.8
7.6
154
973
M08.9
ICD-10 Finland
Juvenile arthritis, unspecified
25.4
7.6
10
*
L04AA24
ATC
abatacept; parenteral
25.4
7.6
10
*
XCD10
NOMESCO Finland
Electrophysiological examination of eye
5.2
7.5
22
44
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
4.7
7.5
24
53
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.5
7.4
60
260
H30.9
ICD-10 Finland
Chorioretinal inflammation, unspecified
81.1
7.4
8
*
H13.1*B02.3
ICD-10 Finland
Zoster conjunctivitis
81.1
7.4
8
*
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
3.3
7.3
35
110
H21.0
ICD-10 Finland
Hyphaema
+∞
7.3
7
*
H17.9
ICD-10 Finland
Corneal scar and opacity, unspecified
+∞
7.3
7
*
H16.8
ICD-10 Finland
Other keratitis
+∞
7.3
7
*
NH3EA
NOMESCO Finland
Feet X-ray examination with load
5.6
7.3
20
37
CHD65
NOMESCO Finland
Nonpenetrating glaucoma surgery
16.0
7.2
11
7
E0000UV
ATC
NA
1.7
7.2
218
1547
K07.60
ICD-10 Finland
Snapping jaw
3.2
7.2
36
118
EG1AA
NOMESCO Finland
Mandibular joint X-ray examination
20.3
7.1
10
5
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
5.7
7.1
19
34
SBB10
NOMESCO Finland
Teeth copy
2.6
7.1
52
214
NH1AE
NOMESCO Finland
Ankle joint ultrasound examination
12.2
7.1
12
10
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
10.2
7.1
13
13
A04AA01
ATC
ondansetron; systemic, rectal
2.6
7.0
49
197
K50.1
ICD-10 Finland
Crohn disease of large intestine
7.1
7.0
16
23
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
3.6
7.0
30
87
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.6
6.9
222
1601
RT160
NOMESCO Finland
NA
16.9
6.8
10
6
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
5.0
6.7
20
41
NA6AA
NOMESCO Finland
Sacro-iliac joint X-ray examination
22.8
6.7
9
*
CD2S4
NOMESCO Finland
Photography of eye
22.8
6.7
9
*
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
2.8
6.7
40
148
H33.0
ICD-10 Finland
Retinal detachment with retinal break
4.4
6.6
22
51
N02AJ06
ATC
codeine and paracetamol; systemic
1.6
6.6
197
1387
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.6
6.5
250
1875
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.6
6.5
45
180
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.4
6.5
52
227
H40.6
ICD-10 Finland
Glaucoma secondary to drugs
70.6
6.4
7
*
NHG24
NOMESCO Finland
Fusion of subtalar joint and between bones of ankle
14.5
6.4
10
7
NG1DA
NOMESCO Finland
X-ray of knees
5.3
6.4
18
35
XX9XE
NOMESCO Finland
Other ultrasound examination
8.3
6.4
13
16
XCH00
NOMESCO Finland
Eye pressure measurement
3.3
6.3
29
90
NHG20
NOMESCO Finland
Fusion of talocrural joint
18.2
6.3
9
5
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
4.9
6.3
19
40
H16.3
ICD-10 Finland
Interstitial and deep keratitis
+∞
6.3
6
*
CGG31
NOMESCO Finland
Posterior corneal lamellar transplantation
+∞
6.3
6
*
7143D
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Juvenile chronic polyarthritis[OLIGARTHRITIS JUVENILIS]
+∞
6.3
6
*
H18.1
ICD-10 Finland
Bullous keratopathy
+∞
6.3
6
*
H20.2
ICD-10 Finland
Lens-induced iridocyclitis
+∞
6.3
6
*
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
3.0
6.2
33
113
CG2T4
NOMESCO Finland
Topography assessment of cornea
27.0
6.2
8
*
A02BC03
ATC
lansoprazole; oral
1.7
6.2
160
1081
H43.1
ICD-10 Finland
Vitreous haemorrhage
4.5
6.1
20
46
UJF30
NOMESCO Finland
Ileoscopy through colon
2.3
6.1
55
256
H35.9
ICD-10 Finland
Retinal disorder, unspecified
10.2
6.1
11
11
H11.3
ICD-10 Finland
Conjunctival haemorrhage
3.4
6.0
27
82
O99.89
ICD-10 Finland
Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
6.1
6.0
15
25
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
122
205
7.08
72.23
4.6
2.3
42.7
40.6
u/l
0.40
112
185
43
12
38.26
69.04
1.7
1.7
109.9
—
au/ml
—
9
0
89
137
7.35
56.72
4.2
2.2
10.2
12.5
mg/l
1.61
84
127
520
3071
4.29
55.33
15.4
9.2
4.0
4.1
e9/l
0.60
487
2703
457
2529
3.63
52.52
13.3
6.0
56.8
57.1
%
0.21
441
2393
459
2569
3.59
51.31
14.1
6.1
28.2
28.1
%
0.09
440
2422
83
166
5.58
40.39
1.8
1.6
0.0
0.1
iu/ml
0.87
15
33
563
3918
4.00
38.17
8.8
3.9
13.0
11.6
mm/h
1.44
530
3614
561
4044
3.60
32.66
12.1
7.6
83.6
79.3
u/l
0.58
536
3802
53
96
5.92
28.47
4.0
3.0
4.1
4.4
e9/l
0.53
53
96
53
97
5.85
28.16
4.1
3.4
56.8
58.1
%
0.31
53
97
23
15
15.85
26.35
2.9
5.8
6.8
9.8
mg/l
1.07
12
15
35
50
7.34
23.53
1.2
1.3
—
—
—
0
0
396
2621
2.28
23.03
5.0
3.6
0.0
0.0
estimate
0.00
101
489
29
34
8.88
22.92
1.8
1.5
32.9
26.7
%
0.31
19
26
398
2653
2.26
22.56
5.0
3.7
0.0
0.0
estimate
0.50
104
479
395
2628
2.26
22.45
6.3
5.0
0.0
0.0
estimate
0.50
106
497
337
2138
2.18
21.13
3.0
2.3
73.8
75.7
nmol/l
0.60
308
1924
26
31
8.69
20.26
1.2
1.3
—
—
—
0
0
355
2333
2.13
19.92
6.7
6.3
1.2
1.2
mmol/l
1.10
320
2110
23
26
9.13
18.64
3.8
3.3
534.9
1003.8
u/ml
1.46
23
26
25
33
7.84
17.93
1.9
2.1
—
—
—
0
0
298
1918
2.01
16.79
3.9
3.2
—
—
—
0
0
369
2566
2.00
16.58
7.7
7.1
1.2
1.2
mmol/l
1.54
294
2173
623
5360
3.97
16.56
24.6
13.7
19.7
23.1
mg/l
2.23
556
4215
327
2186
1.98
16.41
5.1
5.0
35.3
35.7
g/l
0.65
301
2046
276
1749
1.99
16.07
3.0
3.4
2.4
2.4
mmol/l
0.11
242
1530
222
1311
2.05
15.68
2.8
2.2
3.4
3.1
mg/l
0.82
190
1119
455
3454
2.03
15.35
5.3
4.4
6.6
3054.7
e6/l
—
7
61
23
33
7.19
15.35
1.9
2.2
17.8
11.5
%
1.14
13
21
22
31
7.31
14.91
1.4
1.0
1.1
1.1
u/l
0.07
13
16
46
127
3.82
14.80
1.6
1.4
—
—
—
0
0
27
48
5.82
14.72
2.1
1.7
47.5
62.4
%
0.98
17
39
94
398
2.59
14.63
2.3
3.0
66.5
66.7
g/l
0.09
85
362
379
2744
1.90
14.22
5.7
6.6
11.9
11.4
umol/l
0.17
358
2609
188
1101
1.99
13.24
2.5
2.6
4.2
5.9
e6/l
0.83
175
973
128
650
2.20
13.17
3.8
2.5
138.3
127.4
ug/g
0.11
105
525
633
5685
3.88
11.90
20.3
10.2
25.6
27.0
u/l
0.97
613
5490
223
1435
1.84
11.53
6.2
3.9
0.0
0.0
estimate
0.69
103
481
223
1456
1.80
10.88
3.3
3.1
0.3
0.5
e6/l
1.45
179
1083
39
122
3.33
10.43
2.0
1.7
13391.1
17264.8
e6/l
0.20
31
93
238
1611
1.75
10.11
3.4
3.2
162.0
100.9
e6/l
0.18
192
1238
28
73
3.96
9.77
1.1
1.1
—
—
—
0
0
124
692
1.98
9.74
6.0
6.4
1.0
1.0
mmol/l
0.68
118
636
55
220
2.64
9.55
1.5
2.2
1.4
1.5
g/l
0.30
44
193
571
4987
2.09
9.53
20.3
12.6
83.2
82.6
ml/min/173m2
0.26
503
4083
151
908
1.86
9.45
1.9
1.7
1315.3
1183.6
nmol/l
0.88
108
679
96
499
2.08
9.15
2.3
2.0
346.7
374.2
nmol/l
0.61
90
461
78
378
2.21
8.88
4.4
4.3
93.4
82.0
ng/l
0.57
70
336
105
571
2.00
8.83
2.9
4.5
234.5
257.5
u/l
0.85
97
541
529
4550
1.82
8.59
27.5
16.9
13.9
13.7
%
2.48
520
4473
43
160
2.81
8.58
2.7
2.9
—
—
—
0
0
273
1997
1.63
8.25
4.2
3.6
28.3
38.6
ng/l
0.93
185
1357
222
1550
1.65
8.03
2.2
2.1
179.8
299.5
u/l
1.03
205
1468
66
313
2.23
7.92
1.3
1.2
155.0
161.7
u/ml
0.05
61
288
133
816
1.79
7.67
1.8
1.9
—
—
—
0
0
42
165
2.65
7.58
1.9
1.9
—
—
—
0
0
602
5470
2.16
7.38
21.4
15.8
139.3
139.6
mmol/l
2.53
593
5326
96
538
1.92
7.36
4.1
3.1
—
—
—
0
0
556
4926
1.82
7.27
23.9
14.7
39.6
40.1
%
0.61
370
3641
243
1774
1.59
7.16
3.9
3.5
29.8
33.6
u/l
1.47
220
1692
602
5486
2.13
7.06
21.7
15.9
3.9
4.0
mmol/l
2.61
592
5335
17
39
4.45
6.99
1.2
1.1
—
—
—
0
0
641
6012
3.42
6.95
35.2
20.2
133.1
135.8
g/l
4.68
635
5933
131
826
1.73
6.82
2.9
2.4
12.4
13.2
umol/l
0.56
118
764
273
2073
1.54
6.64
5.6
3.7
—
—
—
0
0
123
768
1.74
6.62
2.9
2.4
2.3
2.4
g/l
0.21
112
719
11
9
12.40
6.60
1.1
1.9
—
—
—
0
0
69
364
2.00
6.29
2.0
1.7
—
—
—
0
0
33
128
2.66
6.14
2.5
1.7
—
—
—
0
0
140
925
1.65
6.08
2.9
2.9
2.5
2.4
mmol/l
0.36
122
815
157
1070
1.61
6.01
1.9
1.7
451.8
7494833.1
pmol/l
0.50
128
894
173
1212
1.58
5.89
1.7
1.5
22.2
20.7
nmol/l
0.61
146
1030
32
125
2.64
5.88
1.5
1.6
4.9
3.1
e6/l
0.52
23
95
32
125
2.64
5.88
1.6
1.7
2093.0
1091.9
e6/l
0.20
23
98
377
3118
1.49
5.81
4.9
4.9
6.6
6.7
mmol/l
0.59
359
2911
266
2055
1.49
5.74
2.1
1.9
97.2
96.5
pmol/l
0.08
147
1083
185
1325
1.55
5.69
2.5
2.8
7134.9
8465.5
umol/l
0.12
162
1157
134
890
1.63
5.67
2.9
2.7
0.8
1.0
e6/l
0.73
81
510
30
118
2.62
5.45
1.7
1.4
—
—
—
0
0
93
567
1.75
5.41
1.8
1.9
—
—
—
0
0
112
720
1.67
5.37
3.0
2.4
22.8
22.7
%
0.02
98
625
293
2330
1.46
5.36
3.8
2.8
114.8
124.5
ug/l
0.38
273
2151
36
156
2.38
5.36
2.0
2.6
2.6
1.2
g/l
0.60
31
142
38
169
2.32
5.34
1.9
2.4
3.2
3.2
g/l
0.08
26
135
40
182
2.28
5.33
1.9
2.4
4.9
3.8
g/l
0.48
26
132
40
182
2.28
5.33
1.9
2.4
7.3
7.6
g/l
0.34
27
138
40
182
2.28
5.33
1.9
2.4
—
—
—
0
0
10
18
5.63
5.33
1.1
1.1
1359.7
1775.7
miu/ml
—
10
18
31
126
2.53
5.28
1.3
1.6
—
—
—
0
0
18
54
3.40
5.19
1.2
1.1
—
—
—
0
0
71
407
1.83
5.07
3.3
3.7
1.2
1.2
mmol/l
0.59
59
352
219
1661
1.48
5.04
2.6
2.6
54.1
57.7
u/l
1.01
203
1554
195
1447
1.49
4.99
3.3
3.2
1572.5
1224.1
ng/l
0.60
165
1215
122
818
1.60
4.93
2.5
3.8
0.8
0.8
mmol/l
0.16
111
772
91
566
1.71
4.92
1.8
1.9
—
—
—
0
0
19
62
3.13
4.82
1.2
1.1
—
—
—
0
0
19
63
3.08
4.70
1.2
1.1
—
—
—
0
0
36
167
2.22
4.61
2.0
2.4
9.9
10.4
g/l
0.21
28
147
25
100
2.56
4.43
1.5
1.6
—
—
—
0
0
127
895
1.52
4.10
1.3
1.3
33.6
36.6
iu/ml
0.05
26
281
535
4895
1.49
3.93
4.5
4.6
1.9
2.2
mu/l
0.65
487
4485
23
94
2.50
3.92
2.6
2.4
16.0
16.2
%
0.08
12
50
35
173
2.08
3.87
1.1
1.3
—
—
—
0
0
51
288
1.84
3.85
1.9
1.7
—
—
—
0
0
31
148
2.15
3.74
1.9
2.4
38.4
37.3
g/l
0.56
26
129
205
1614
1.39
3.65
3.0
3.2
7.5
7.7
mmol/l
0.34
172
1364
17
62
2.79
3.61
2.9
2.0
31.1
33.7
pg
1.34
17
62
154
1166
1.42
3.41
1.7
1.9
1.3
1.2
mg/l
0.22
116
885
30
148
2.08
3.36
1.7
4.0
42.2
102.0
mg/l
0.78
20
122
30
148
2.08
3.36
1.7
4.0
35.4
33.0
mg/l
0.10
21
124
90
616
1.53
3.31
2.7
3.4
13.5
8.3
umol/l
0.59
73
540
30
149
2.06
3.30
1.1
1.2
—
1.6
—
0
5
52
311
1.73
3.28
2.0
1.5
—
—
—
0
0
7
12
5.88
3.02
1.0
1.0
—
—
—
0
0
5
5
10.06
2.98
1.0
1.0
—
—
—
0
0
17
69
2.50
2.98
1.6
1.6
—
—
—
0
0
449
4058
1.33
2.96
3.7
3.9
15.1
14.7
pmol/l
1.70
408
3684
13
46
2.86
2.93
1.3
1.8
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
30
158
1.94
2.85
3.0
2.9
0.3
0.3
u/ml
0.08
16
83
55
348
1.63
2.84
3.1
4.3
1.5
1.8
mmol/l
0.19
38
259
88
621
1.48
2.82
8.7
7.2
—
—
—
0
0
158
1239
1.36
2.80
1.3
1.3
1.9
1.5
u/ml
0.15
46
339
8
18
4.49
2.80
1.3
1.3
—
—
—
0
0
154
1203
1.37
2.80
5.9
3.9
1.0
1.0
kg/l
0.13
14
166
109
804
1.43
2.77
1.9
2.3
29.9
29.8
s
0.06
104
780
19
85
2.27
2.72
1.4
1.8
—
—
—
0
0
29
154
1.92
2.70
2.3
1.5
—
—
—
0
0
520
4829
1.36
2.69
6.0
5.6
39.4
39.8
mmol/mol
0.32
477
4501
292
2510
1.29
2.69
4.0
4.1
—
—
—
0
0
17
73
2.36
2.67
1.1
1.2
—
—
—
0
0
16
69
2.35
2.50
1.6
1.5
—
—
—
0
0
26
138
1.92
2.44
1.1
1.3
—
—
—
0
0
394
3546
1.28
2.42
3.3
3.1
—
—
—
0
0
10
34
2.97
2.42
1.3
1.2
2.0
1.9
mmol/l
—
10
34
111
842
1.38
2.41
3.3
2.9
1.9
2.3
e6/l
0.35
59
463
71
497
1.48
2.38
2.1
2.4
0.2
0.2
g/l
0.16
66
464
158
1269
1.32
2.36
2.5
2.3
—
—
—
0
0
15
65
2.34
2.33
1.1
1.1
—
—
—
0
0
71
500
1.47
2.32
2.9
2.6
35.1
34.7
u/l
0.03
57
427
5
9
5.59
2.21
1.4
1.2
—
—
—
0
0
187
1554
1.28
2.16
4.2
4.0
12.5
9.4
mg/mmol
0.23
117
991
23
123
1.90
2.14
1.2
1.5
104.0
110.5
u/ml
—
7
24
31
504
0.60
2.13
1.8
1.6
—
—
—
0
0
13
55
2.39
2.13
1.4
1.9
—
—
—
0
0
8
25
3.23
2.10
5.4
2.5
24.0
366.4
ug/l
—
8
20
21
111
1.92
2.03
1.0
1.2
—
1.2
—
0
8
8
26
3.10
2.02
1.1
1.0
—
—
—
0
0
541
5117
1.32
2.01
4.4
4.4
6.0
5.9
mmol/l
0.19
483
4685
9
33
2.75
1.93
1.2
1.1
—
—
—
0
0
127
1018
1.31
1.92
1.6
1.6
—
—
—
0
0
18
92
1.98
1.91
1.6
1.6
—
—
—
0
0
14
65
2.18
1.89
1.4
1.8
—
—
—
0
0
12
52
2.33
1.88
3.1
2.1
—
—
—
0
0
28
167
1.71
1.87
2.0
1.4
1.2
1.2
g/l
0.22
28
158
391
3574
1.23
1.86
3.5
3.2
49.3
48.0
u/l
0.10
353
3364
17
86
2.00
1.86
1.1
1.1
—
—
—
0
0
40
262
1.56
1.86
8.5
10.4
24.9
24.5
mmol/l
0.31
35
246
10
40
2.52
1.84
1.1
1.2
—
94.4
—
0
5
557
5307
1.32
1.82
4.9
4.8
2.7
2.8
mmol/l
1.29
506
4898
5
12
4.19
1.82
1.2
1.4
—
—
—
0
0
16
80
2.02
1.81
1.6
1.5
—
—
—
0
0
7
23
3.06
1.80
1.6
1.3
—
—
—
0
0
8
29
2.78
1.79
1.1
1.7
—
—
—
0
0
8
29
2.78
1.79
1.1
1.5
—
—
—
0
0
8
29
2.78
1.79
1.1
1.7
—
—
—
0
0
8
30
2.69
1.73
1.1
1.1
—
—
—
0
0
77
583
1.36
1.72
5.5
7.6
1.2
1.2
mmol/l
0.04
57
453
5
13
3.87
1.72
1.2
2.0
1.2
2.5
ug/l
—
5
5
5
13
3.87
1.72
1.0
2.2
—
—
—
0
0
8
31
2.60
1.66
1.1
1.3
—
32.0
—
0
5
120
974
1.28
1.65
4.5
3.8
558.1
391.9
ng/l
0.18
100
748
45
313
1.47
1.62
2.6
3.5
4.5
4.6
pmol/l
0.22
36
274
76
586
1.34
1.53
5.5
7.5
11.5
12.3
kpa
1.02
71
561
11
51
2.18
1.51
1.1
1.2
—
—
—
0
0
11
51
2.18
1.51
1.1
1.2
—
—
—
0
0
11
51
2.18
1.51
1.1
1.2
—
—
—
0
0
56
414
1.39
1.47
2.2
2.6
66.4
66.8
ml/min/173m2
0.02
27
181
107
872
1.27
1.44
1.3
1.2
13.8
11.8
u/ml
0.09
37
330
5
16
3.14
1.44
1.6
1.1
—
—
—
0
0
5
16
3.14
1.44
1.8
1.1
92.2
97.3
%
—
5
16
23
141
1.65
1.43
1.1
1.1
—
—
—
0
0
35
239
1.49
1.40
3.2
4.9
24.8
24.9
mmol/l
0.11
28
228
7
29
2.43
1.39
1.6
1.6
—
—
—
0
0
81
641
1.30
1.37
35.5
22.2
1.8
1.3
inr
—
8
86
58
437
1.36
1.37
1.9
2.5
4.3
7.8
ug/l
1.95
45
394
6
23
2.62
1.37
1.7
1.7
—
—
—
0
0
6
24
2.51
1.30
1.7
1.7
—
—
—
0
0
8
34
2.37
1.29
1.6
1.2
—
—
—
0
0
11
55
2.02
1.28
1.4
1.8
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
35
2.30
1.27
1.1
1.2
—
—
—
0
0
20
123
1.65
1.25
1.5
1.7
—
—
—
0
0
189
1661
1.19
1.24
4.7
4.7
3.0
2.5
ug/l
0.23
167
1502
8
36
2.24
1.24
1.3
1.4
4.6
8.9
u/l
—
8
29
9
45
2.01
1.23
1.4
2.7
—
—
—
0
0
541
5198
1.23
1.23
4.5
4.2
1.5
1.5
mmol/l
0.84
488
4806
5
19
2.64
1.22
3.2
5.7
—
—
—
0
0
5
19
2.64
1.22
1.2
1.1
—
93.4
—
0
11
30
206
1.48
1.19
1.7
1.8
—
—
—
0
0
543
5225
1.22
1.18
4.5
4.3
4.6
4.7
mmol/l
0.68
492
4847
10
50
2.02
1.17
1.3
1.4
—
—
—
0
0
10
50
2.02
1.17
1.1
1.2
—
—
—
0
0
10
50
2.02
1.17
1.1
1.2
—
—
—
0
0
78
629
1.27
1.16
4.8
4.3
34.7
31.5
%
1.53
52
414
5
20
2.51
1.15
1.0
1.1
—
—
—
0
0
5
20
2.51
1.15
1.4
2.2
25.0
27.9
umol/l
—
5
20
10
51
1.98
1.11
1.1
1.3
—
—
—
0
0
28
193
1.47
1.11
1.6
1.7
—
—
—
0
0
14
81
1.74
1.09
1.1
1.1
—
—
—
0
0
9
46
1.97
1.04
1.3
1.2
—
—
—
0
0
5
22
2.28
1.03
1.2
1.1
70.2
12.6
u/l
—
5
16
9
47
1.93
1.02
1.0
1.0
—
—
—
0
0
522
5026
1.19
1.01
3.9
3.9
1.3
1.3
mmol/l
0.00
467
4632
5
23
2.18
0.98
1.2
1.1
106.6
68.4
u/l
—
5
17
0
29
0.00
0.98
0.0
2.3
—
46.7
—
0
22
7
36
1.95
0.97
1.6
1.6
—
—
—
0
0
29
209
1.41
0.94
3.8
1.9
2.4
3.8
mg/l
0.77
24
147
19
126
1.52
0.92
1.5
1.7
—
—
—
0
0
27
194
1.41
0.89
3.0
2.1
2038.1
4507.6
u/l
0.48
14
77
156
1387
1.16
0.89
1.6
1.7
1.4
1.4
mmol/l
0.22
122
1173
113
983
1.18
0.85
3.3
2.9
0.7
0.8
ug/l
0.69
83
614
8
45
1.79
0.84
1.3
1.1
81.1
47.6
u/l
—
8
27
10
57
1.77
0.84
6.3
3.5
2.9
4.0
nmol/l
—
10
57
12
73
1.66
0.82
1.7
1.6
—
—
—
0
0
21
148
1.43
0.78
1.6
1.6
—
—
—
0
0
20
140
1.44
0.77
1.2
1.3
—
—
—
0
0
19
132
1.45
0.76
1.3
1.3
—
—
—
0
0
9
53
1.71
0.75
3.1
4.3
—
—
—
0
0
20
141
1.43
0.75
3.1
2.8
24.4
24.4
mmol/l
0.01
20
121
5
24
2.09
0.74
1.0
1.0
—
—
—
0
0
31
237
1.32
0.74
1.3
1.5
—
—
—
0
0
13
84
1.56
0.72
1.3
1.5
—
—
—
0
0
19
134
1.43
0.72
1.2
1.3
217.0
226.8
u/ml
—
8
78
60
503
1.21
0.69
3.8
4.4
4.3
36.7
ug/l
1.27
49
416
18
127
1.43
0.68
1.3
1.9
2.0
7.0
iu/l
—
6
41
11
70
1.58
0.65
1.0
1.0
—
—
—
0
0
19
137
1.40
0.65
1.5
1.4
—
—
—
0
0
22
163
1.36
0.65
1.8
1.4
—
—
—
0
0
21
156
1.36
0.61
2.3
4.4
8.1
8.6
kpa
0.76
21
143
21
158
1.34
0.58
2.0
3.9
4.2
3.6
g/l
0.98
21
153
6
35
1.72
0.58
1.8
1.2
—
—
—
0
0
6
37
1.63
0.55
1.3
1.5
—
—
—
0
0
22
168
1.32
0.55
1.4
1.1
—
—
—
0
0
21
160
1.32
0.54
1.1
1.3
—
—
—
0
0
22
169
1.31
0.54
1.4
1.1
—
—
—
0
0
68
593
1.16
0.53
2.0
2.1
—
—
—
0
0
9
62
1.46
0.53
1.4
1.7
14.2
16.2
ug/l
—
9
62
7
49
1.43
0.46
1.7
1.7
—
—
—
0
0
7
49
1.43
0.46
1.7
1.3
—
—
—
0
0
7
49
1.43
0.46
1.7
1.7
—
—
—
0
0
7
49
1.43
0.46
1.0
1.2
—
—
—
0
0
7
49
1.43
0.46
1.7
1.7
—
—
—
0
0
45
386
1.18
0.45
3.5
3.1
151.0
201.6
ng/l
0.75
39
350
18
139
1.30
0.44
1.2
1.5
—
—
—
0
0
11
78
1.42
0.43
1.5
1.4
—
—
—
0
0
11
78
1.42
0.43
1.5
1.4
—
—
—
0
0
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
11
79
1.40
0.41
1.5
1.4
—
—
—
0
0
11
79
1.40
0.41
1.5
1.4
—
—
—
0
0
11
79
1.40
0.41
1.5
1.4
—
—
—
0
0
11
79
1.40
0.41
1.5
1.4
—
—
—
0
0
9
66
1.37
0.38
1.4
1.3
0.6
0.6
nmol/l
—
9
60
5
36
1.39
0.38
1.4
1.8
—
—
—
0
0
5
36
1.39
0.38
1.0
1.3
—
—
—
0
0
5
36
1.39
0.38
1.4
1.5
—
—
—
0
0
5
36
1.39
0.38
1.0
1.3
—
—
—
0
0
9
67
1.35
0.38
1.3
1.2
—
—
—
0
0
13
98
1.33
0.37
1.5
1.3
—
—
—
0
0
13
98
1.33
0.37
1.5
1.3
—
—
—
0
0
32
375
0.85
0.37
1.2
1.2
36.9
155.6
iu/ml
—
8
148
5
77
0.65
0.36
2.8
2.6
3.5
58.2
u/ml
—
5
71
6
42
1.43
0.35
1.3
1.2
—
—
—
0
0
6
42
1.43
0.35
1.3
1.2
—
—
—
0
0
18
221
0.81
0.34
2.3
4.8
1.5
1.5
%
0.07
18
204
13
101
1.29
0.32
1.5
1.8
—
—
—
0
0
142
1342
1.07
0.30
4.7
4.1
21.5
21.1
%
0.12
73
609
7
55
1.28
0.30
1.1
1.2
—
—
—
0
0
10
76
1.32
0.28
1.2
1.4
20.3
21.6
u/l
—
10
63
8
64
1.25
0.27
1.4
1.4
2.2
3.0
ug/l
—
8
55
58
529
1.11
0.27
5.0
4.6
1.6
1.8
mmol/l
0.14
46
423
16
193
0.82
0.27
1.8
1.7
—
—
—
0
0
9
77
1.17
0.24
1.1
1.1
1.6
1.5
g/l
—
9
70
12
97
1.24
0.23
1.1
1.1
0.4
3.3
u/ml
—
7
44
64
689
0.92
0.22
1.7
1.7
1.5
1.5
%
0.16
53
610
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
10
81
1.24
0.19
1.1
1.3
—
—
—
0
0
32
349
0.91
0.16
2.7
2.1
—
—
—
0
0
40
428
0.93
0.13
2.4
2.1
11.8
13.4
nmol/l
0.64
33
389
10
85
1.18
0.12
1.6
1.2
4.8
5.8
u/ml
—
5
24
14
158
0.88
0.12
1.3
1.5
—
—
—
0
0
68
656
1.04
0.09
2.3
2.2
—
—
—
0
0
14
127
1.10
0.08
1.2
1.4
—
—
—
0
0
14
127
1.10
0.08
1.2
1.4
—
—
—
0
0
14
127
1.10
0.08
1.2
1.4
—
—
—
0
0
14
127
1.10
0.08
1.2
1.4
—
—
—
0
0
9
87
1.03
0.07
1.1
1.1
—
—
—
0
0
16
169
0.95
0.03
2.0
1.7
35.4
39.4
nmol/l
0.46
16
163
12
112
1.07
0.03
1.3
1.6
—
—
—
0
0
11
118
0.93
0.03
1.5
1.8
211.8
229.0
pmol/l
0.44
11
111
13
138
0.94
0.02
1.8
1.8
—
—
—
0
0
29
281
1.03
0.02
4.4
3.6
1.2
1.3
%
0.02
29
281
30
291
1.03
0.02
1.6
1.3
—
—
—
0
0
27
278
0.97
0.02
2.6
2.0
—
—
—
0
0
29
285
1.02
0.00
1.1
1.0
—
—
—
0
0
79
788
1.00
0.00
1.6
1.5
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.9
—
0.5
—
0
8
0
6
0.00
0.00
0.0
1.0
—
12.4
—
0
6
7
75
0.93
0.00
1.1
1.5
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
65.7
—
0
6
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
9
96
0.94
0.00
1.7
1.6
—
—
—
0
0
6
63
0.95
0.00
2.0
2.2
13.3
12.9
%
—
6
63
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint H7_IRIDOCYCLITISINOTH and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H7_IRIDOCYCLITISINOTH | 1.095 [0.91, 1.31] | 0.326 |
| Birth year | 0.994 [0.99, 1.0] | 0.156 |
During the follow-up period (1.1.1998 — 31.12.2019), 252 out of 1718 females with H7_IRIDOCYCLITISINOTH died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H7_IRIDOCYCLITISINOTH | 1.374 [1.14, 1.66] | 0.001 |
| Birth year | 0.985 [0.98, 0.99] | 0.003 |
During the follow-up period (1.1.1998 — 31.12.2019), 266 out of 1621 males with H7_IRIDOCYCLITISINOTH died.
Mortality risk
Mortality risk for people of age
years, who have H7_IRIDOCYCLITISINOTH.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.099% | 0.265% |
| 5 | 0.543% | 1.506% |
| 10 | 1.49% | 3.577% |
| 15 | 2.793% | 6.832% |
| 20 | 5.292% | 11.356% |
Relationships between endpoints
↥Index endpoint: H7_IRIDOCYCLITISINOTH – Iridocyclitis in diseases classified elsewhere
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data